Published in Endokrynol Pol on January 01, 1987
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest (1993) 5.06
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia (1986) 4.54
Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med (1997) 4.18
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology (1993) 3.98
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 3.63
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab (1986) 2.80
Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nat Genet (1996) 2.70
The incretin concept today. Diabetologia (1979) 2.18
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion (1987) 1.73
Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol (1989) 1.72
Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion (1993) 1.71
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab (1996) 1.70
Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia (1985) 1.67
Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol (1974) 1.63
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab (1993) 1.61
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut (1996) 1.53
Gastrin and G-cells in the antral mucosa of patients with pernicious anaemia, acromegaly and hyperparathyroidism and in a Zollinger-Ellison tumour of the pancreas. Eur J Clin Invest (1971) 1.52
Mucosal gastrin concentration, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer. Gut (1976) 1.42
Trans fatty acids in human milk in Poland and their association with breastfeeding mothers' diets. Acta Paediatr (2003) 1.42
Aluminum contamination of parenteral nutrition additives, amino acid solutions, and lipid emulsions. Nutrition (1999) 1.40
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Diabetologia (1996) 1.37
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion (1988) 1.34
Aetiology and pathogenesis of pancreatitis. (Current concepts). Scand J Gastroenterol Suppl (1970) 1.29
Clustering of private mutations in the congenital chloride diarrhea/down-regulated in adenoma gene. Hum Mutat (1998) 1.28
Gastrointestinal peptides and insulin secretion. Diabetes Metab Rev (1987) 1.27
The influence of glucagon on acute experimental pancreatitis in the rat. Scand J Gastroenterol (1974) 1.26
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Hypoglycaemia. 1. Insulin secreting tumours. Clin Endocrinol Metab (1976) 1.22
Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik (1975) 1.22
Liver diseases and diabetes mellitus. Prog Liver Dis (1970) 1.21
Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol (1975) 1.20
Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. J Clin Endocrinol Metab (1989) 1.17
Genetic background of congenital chloride diarrhea in high-incidence populations: Finland, Poland, and Saudi Arabia and Kuwait. Am J Hum Genet (1998) 1.17
DNA barcoding in Mucorales: an inventory of biodiversity. Persoonia (2013) 1.16
New developments in the incretin concept. Diabetologia (1985) 1.15
Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (1987) 1.13
Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia (1973) 1.10
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol (1995) 1.09
Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. Digestion (1990) 1.09
Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia (1980) 1.08
Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion (1988) 1.08
Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats. Diabetologia (1984) 1.07
Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett (1976) 1.07
Inhibition of gastric secretion by calcitonin in man. Horm Metab Res (1971) 1.06
Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass. Eur J Pediatr Surg (2003) 1.05
Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy. Diabetologia (1976) 1.05
Somatostatin and the stomach: exocrine and endocrine aspects. Metabolism (1978) 1.04
[Calcitonin-induced inhibition of exocrine pancreatic secretion in man]. Dtsch Med Wochenschr (1971) 1.04
Analysis of the inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport. Diabetologia (1971) 1.02
Mechanism of insulin resistance in CCl4-induced cirrhosis of rats. Gastroenterology (1992) 1.02
[Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. Dtsch Med Wochenschr (1975) 1.01
The possible role of phospholipase A in the pathogenesis of acute pancreatitis. Scand J Gastroenterol (1969) 1.01
Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man. Scand J Gastroenterol Suppl (1985) 0.98
Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia (1978) 0.98
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol (1991) 0.98
Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion. Pediatr Transplant (1999) 0.97
Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion (1982) 0.97
[Hypoglycemia factitia. A differential diagnostic significant form of hyperinsulinism]. Dtsch Med Wochenschr (1969) 0.97
Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut (1982) 0.97
Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion (1986) 0.96
Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology (1987) 0.96
Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency. Eur J Clin Invest (2001) 0.96
The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection. Vaccine (2000) 0.96
Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Gastroenterology (1979) 0.95
The family structure of the Mucorales: a synoptic revision based on comprehensive multigene-genealogies. Persoonia (2013) 0.95
Serum and salivary antigliadin antibodies and serum IgA anti-endomysium antibodies as a screening test for coeliac disease. Acta Paediatr (1996) 0.95
Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis. Gut (1990) 0.94
The morphological substrate of the inhibition of insulin secretion by diazoxide. Horm Metab Res (1969) 0.94
Gastrointestinal somatostatin: extraction and radioimmunoassay in different species. Gut (1978) 0.93
Somatostatin therapy of acute experimental pancreatitis. Gut (1977) 0.93
Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol (1987) 0.93
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. Scand J Gastroenterol Suppl (1989) 0.93
Etiology and incidence of acute pancreatitis: a 20-year study in a single institution. Digestion (1989) 0.92
Increase of intestinal brush border hydrolases in mucosa of streptozotocin-diabetic rats. Diabetologia (1972) 0.91
Congenital chloride diarrhoea in Poland. Mater Med Pol (1988) 0.91
Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. Horm Metab Res (1991) 0.91
The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver. Scand J Gastroenterol (1970) 0.91
Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterology (1986) 0.91
Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Scand J Gastroenterol (1984) 0.90
Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis (2008) 0.90
Histochemistry, ultrastructure and hormone content of human insulinomas. Horm Metab Res (1976) 0.90
Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects. Acta Diabetol (1995) 0.90
Plasma cholecystokinin levels in patients with chronic pancreatitis. Digestion (1985) 0.90
Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology (1988) 0.89
Influence of secretin on the course of acute experimental pancreatitis in rats. Digestion (1983) 0.89
Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer (1990) 0.89
Disturbances of the entero-insular axis. Scand J Gastroenterol Suppl (1983) 0.89
Inhibition of intestinal amino acid transport by blood sugar lowering biguanides. Diabetologia (1973) 0.89
[Exocrine pancreatic function in chronic kidney failure]. Verh Dtsch Ges Inn Med (1968) 0.89
Functional reserve capacity of the exocrine pancreas. Digestion (1986) 0.89
In vitro studies of the rate of proinsulin and insulin turnover in seven human insulinomas. Eur J Clin Invest (1973) 0.89
Identification of seven novel mutations including the first two genomic rearrangements in SLC26A3 mutated in congenital chloride diarrhea. Hum Mutat (2001) 0.89
Pituitary adenylate cyclase activating peptide, a novel VIP-like gut-brain peptide, relaxes the guinea-pig taenia caeci via apamin-sensitive potassium channels. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Cirrhosis of the liver. On the aetiology, pathogenesis, results of treatment and period of survival in an unselected series of 560 patients. Ger Med Mon (1966) 0.88
Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Eur J Clin Invest (1979) 0.87
Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. J Mol Endocrinol (1993) 0.87
Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med (1987) 0.87
Effects of galanin, its analogues and fragments on rat isolated fundus strips. Br J Pharmacol (1990) 0.87